BIO-TECHNE Corp cotiza a 72.46 USD y tiene una capitalización bursátil de $11.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences seg…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.52 | $0.53 | $0.46 |
| Estimado | $0.45 | $0.52 | $0.53 | $0.43 |
| Sorpresa | — | +0.0% | +0.0% | +7.0% |
| Métrica | TECH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 65.8% | 57.0% | +8.7% |
| Operating Margin | 20.7% | -38.6% | +59.3% |
| Net Margin | 15.0% | -33.6% | +48.5% |
| FCF Margin | 21.7% | -13.9% | +35.5% |
| ROE | 8.6% | -40.4% | +49.0% |
| ROA | 7.0% | -32.0% | +39.0% |
| Current Ratio | 4.55 | 2.84 | +1.71 |
| Debt / Equity | 0.09 | 0.28 | -0.19 |